Table 2.

Median survival time and survival rate in the treatment groups

GroupFaDu xenograft miceSCC40 xenograft mice
nSurvival rate (%)Median survival time (95% CI), dnSurvival rate (%)Median survival time (95% CI), d
Control50.019 (15-28)60.027 (20-34)
Cisplatin520.023 (13-∞)50.022 (16-46)
CCI-77960.035 (28-40)540.052 (34-∞)
Cisplatin + CCI-779616.728 (28-37)640.055 (39-∞)
XRT60.037 (33-40)616.735 (34-39)
Cisplatin + XRT633.347.5 (26-∞)60.038 (36-43)
CCI-779 + XRT666.7>56 (56-∞)616.749 (46-57)
Cisplatin + CCI-779 + XRT616.752 (42-58)666.7>50 (50-∞)